Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2023-12-21 00:00:00 ET · period of report 2023-12-19 · accession 0001437749-23-035161 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-12-21 | 2023-12-19+ | LMAT | Roberts David B | Pres, Dir | M - OptEx | $0.00 | +50 | 12.6K | +0.4% | $0 |
| DM | 2023-12-21 | 2023-12-19+ | LMAT | Roberts David B | Pres, Dir | F - Tax | $55.58 | -422 | 12.6K | -3% | -$23.5K |
| DM | 2023-12-21 | 2023-12-19+ | LMAT | Roberts David B | Pres, Dir | M - OptEx | $0.00 | -50 | 16.20 | -76% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-19 | M | A | 33 | $0.00 | 12,843 | D | — | — | (F1) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. |
| 2 | Common | Common Stock | 2023-12-20 | F | D | 169 | $54.85 | 12,438 | D | — | — | (F4) These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/20/2019. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. |
| 3 | Common | Common Stock | 2023-12-20 | M | A | 15 | $0.00 | 12,607 | D | — | — | (F1) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. |
| 4 | Common | Common Stock | 2023-12-19 | M | A | 2 | $0.00 | 12,592 | D | — | — | (F2) Represents shares acquired from the release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. |
| 5 | Common | Common Stock | 2023-12-19 | F | D | 253 | $56.06 | 12,590 | D | — | — | (F3) These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/19/2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. |
| 6 | Derivative | Dividend Equivalent Rights | 2023-12-19 | M | D | 2 | $0.00 | 0 | D | — · — to — | 2 Common Stock | (F5) These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/19/2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| 7 | Derivative | Dividend Equivalent Rights | 2023-12-19 | M | D | 33 | $0.00 | 2.55 | D | — · — to — | 33 Common Stock | (F5) These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/19/2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| 8 | Derivative | Dividend Equivalent Rights | 2023-12-20 | M | D | 15 | $0.00 | 16.20 | D | — · — to — | 15 Common Stock | (F6) These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/20/2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |